STOCKHOLDERS' EQUITY (Tables)

3 Months Ended

Mar. 31, 2023

STOCKHOLDERS' EQUITY

Schedule of common stock issued roll forward

​	Three Months Ended March 31,
	2023	2022
Common stock:
Balance, beginning of year	171,656,030	155,516,284
Shares issued for stock options exercised	113,208	723,194
Agent growth incentive stock compensation	656,436	510,672
Agent equity stock compensation	2,106,369	1,550,455
Balance, end of quarter	174,532,043	158,300,605

Changes in the Company's stock compensation liability

		Amount
Stock grant liability balance at December 31, 2021	$	4,341
Stock grant liability increase year to date		2,056
Stock grants reclassified from liability to equity year to date		(2,512)
Balance, December 31, 2022		$ 3,885
Stock grant liability increase year to date		993
Stock grants reclassified from liability to equity year to date		-
Balance, March 31, 2023		$ 4,878

Schedule of shares repurchased

	Three Months Ended March 31,
	2023	2022
Treasury stock:
Balance, beginning of year	18,816,791	6,751,692
Repurchases of common stock	2,272,831	1,132,048
Balance, end of quarter	21,089,622	7,883,740